Crossmark

A caged E3 ligase ligand for PROTAC-mediated protein degradation with light

Crossref DOI link: https://doi.org/10.1039/D0CC00523A

Published Online: 2020

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Kounde, Cyrille S. https://orcid.org/0000-0001-6944-8717
Shchepinova, Maria M.

Saunders, Charlie N. https://orcid.org/0000-0001-7221-1358
Muelbaier, Marcel https://orcid.org/0000-0002-5414-0258
Rackham, Mark D.

Harling, John D. https://orcid.org/0000-0003-3602-324X
Tate, Edward W. https://orcid.org/0000-0003-2213-5814
Funding

Funding for this research was provided by:

Engineering and Physical Sciences Research Council (EP/F500416/1, EP/R512540/1)

Biotechnology and Biological Sciences Research Council (BB/N016947/1, BB/S001565/1)

GlaxoSmithKline
License Information

Version of Record valid from 2020-10-23
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Cyrille S. Kounde (ORCID)

: Charlie N. Saunders (ORCID)

: Marcel Muelbaier (ORCID)

: John D. Harling (ORCID)

: Edward W. Tate (ORCID)

PEER REVIEW METHOD

: Authors can choose between single-blind and double-blind peer review

PUBLICATION HISTORY

: Received 20 January 2020; Accepted 31 March 2020; Accepted Manuscript published 3 April 2020; Advance Article published 16 April 2020; Version of Record published 21 May 2020